Select Medical to Release Q1 2026 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy SEM?
Source: PRnewswire
- Earnings Release Schedule: Select Medical will release its financial results for the first quarter ended March 31, 2026, after market close on April 30, 2026, highlighting the company's operational performance in the critical illness recovery sector.
- Conference Call Details: The company will host a conference call on May 1, 2026, at 9:00 AM ET to discuss its financial results and business outlook, enhancing investor understanding of its strategic direction.
- Webcast Availability: The conference call will be available via live webcast, accessible through the company's website, ensuring transparency and improving engagement with investors.
- Business Scale Overview: As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., demonstrating its leadership position and extensive market coverage in the industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SEM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SEM
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 16.370
Low
17.00
Averages
18.75
High
21.00
Current: 16.370
Low
17.00
Averages
18.75
High
21.00
About SEM
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Select Medical to Release Q1 2026 Financial Results
- Earnings Release Schedule: Select Medical will release its financial results for the first quarter ended March 31, 2026, after market close on April 30, 2026, highlighting the company's operational performance in the critical illness recovery sector.
- Conference Call Details: The company will host a conference call on May 1, 2026, at 9:00 AM ET to discuss its financial results and business outlook, enhancing investor understanding of its strategic direction.
- Webcast Availability: The conference call will be available via live webcast, accessible through the company's website, ensuring transparency and improving engagement with investors.
- Business Scale Overview: As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., demonstrating its leadership position and extensive market coverage in the industry.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies like Select Medical Holdings Corporation, Day One Biopharmaceuticals, and Veris Residential for potential violations of federal securities laws and fiduciary duties to shareholders, with transaction prices at $16.50, $21.50, and $19.00 per share, respectively, which may impact shareholder rights.
- Shareholder Rights Protection: The law firm encourages shareholders to contact them to discuss their rights and options, promising to handle matters on a no-cost basis, aiming to secure increased consideration and additional disclosures for shareholders, thereby protecting investor interests.
- Legal Service Model: Halper Sadeh LLC operates on a contingent fee basis, meaning shareholders do not incur legal fees unless the case is successful, which reduces financial risk for shareholders and enhances their willingness to engage in legal action.
- Global Investor Support: The firm represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, demonstrating its expertise and influence in safeguarding investor rights.
See More
M&A Deal Closures Present Opportunities: Target Janus Henderson and Other Stocks.
- Merger and Acquisition Activity: The year has seen significant merger and acquisition activity, with many deals nearing closure.
- Stock Performance: Stocks of companies being acquired are expected to rise upon the completion of these deals.
See More
Opportunities Arise from Finalizing M&A Deals: Target Janus Henderson and Other Stocks.
- Merger and Acquisition Activity: The year has seen significant merger and acquisition activity, with many deals nearing closure.
- Stock Performance: Stocks of companies involved in these acquisitions are expected to rise once the deals are finalized.
See More
Kaskela Law Investigates Select Medical's $16.50 Buyout Proposal
- Investigation of Buyout Proposal: Kaskela Law is investigating Select Medical's buyout proposal at $16.50 per share to determine if the price is fair, which could significantly impact shareholder returns.
- Transaction Background: On March 2, 2026, Select Medical announced an agreement with an investment consortium for acquisition, resulting in shareholders being cashed out and the company's shares ceasing to be publicly traded, thus eliminating their investment options.
- Conflict of Interest Issues: The investigation has revealed significant conflicts of interest in the transaction's structure, potentially rendering the sales process and proposed price unfair to shareholders, especially given that at least one analyst maintained a price target of $19.00 per share.
- Shareholder Action Recommendation: Shareholders of Select Medical are encouraged to contact Kaskela Law for more information regarding their legal rights and options, indicating a potential dissatisfaction with the transaction and a desire for legal recourse.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Select Medical Holdings Corporation (NYSE: SEM) for potential violations of federal securities laws related to its sale to a consortium of executives and directors for $16.50 per share, which may limit shareholder rights.
- FONAR Transaction: FONAR Corporation (NASDAQ: FONR) plans to sell its Class B common stock for $19.00 per share and Class C common stock for $6.34 per share, involving the CEO and certain executives, raising concerns about fiduciary duties to shareholders.
- NorthWestern Energy Deal: NorthWestern Energy Group, Inc. (NASDAQ: NWE) is set to sell to Black Hills Corp. for 0.98 shares of Black Hills per share of NorthWestern, resulting in shareholders owning approximately 44% of the combined entity, which may impact their future interests.
- Shareholder Rights Protection: Halper Sadeh LLC aims to secure increased consideration, additional disclosures, and other relief for shareholders, emphasizing the importance of protecting investor rights and ensuring fair treatment in corporate transactions.
See More
Select Medical to Release Q1 2026 Financial Results
- Earnings Release Schedule: Select Medical will release its financial results for the first quarter ended March 31, 2026, after market close on April 30, 2026, highlighting the company's operational performance in the critical illness recovery sector.
- Conference Call Details: The company will host a conference call on May 1, 2026, at 9:00 AM ET to discuss its financial results and business outlook, enhancing investor understanding of its strategic direction.
- Webcast Availability: The conference call will be available via live webcast, accessible through the company's website, ensuring transparency and improving engagement with investors.
- Business Scale Overview: As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across the U.S., demonstrating its leadership position and extensive market coverage in the industry.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Investigation Background: Halper Sadeh LLC is investigating companies like Select Medical Holdings Corporation, Day One Biopharmaceuticals, and Veris Residential for potential violations of federal securities laws and fiduciary duties to shareholders, with transaction prices at $16.50, $21.50, and $19.00 per share, respectively, which may impact shareholder rights.
- Shareholder Rights Protection: The law firm encourages shareholders to contact them to discuss their rights and options, promising to handle matters on a no-cost basis, aiming to secure increased consideration and additional disclosures for shareholders, thereby protecting investor interests.
- Legal Service Model: Halper Sadeh LLC operates on a contingent fee basis, meaning shareholders do not incur legal fees unless the case is successful, which reduces financial risk for shareholders and enhances their willingness to engage in legal action.
- Global Investor Support: The firm represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors in the past, demonstrating its expertise and influence in safeguarding investor rights.
See More
M&A Deal Closures Present Opportunities: Target Janus Henderson and Other Stocks.
- Merger and Acquisition Activity: The year has seen significant merger and acquisition activity, with many deals nearing closure.
- Stock Performance: Stocks of companies being acquired are expected to rise upon the completion of these deals.
See More
Opportunities Arise from Finalizing M&A Deals: Target Janus Henderson and Other Stocks.
- Merger and Acquisition Activity: The year has seen significant merger and acquisition activity, with many deals nearing closure.
- Stock Performance: Stocks of companies involved in these acquisitions are expected to rise once the deals are finalized.
See More
Kaskela Law Investigates Select Medical's $16.50 Buyout Proposal
- Investigation of Buyout Proposal: Kaskela Law is investigating Select Medical's buyout proposal at $16.50 per share to determine if the price is fair, which could significantly impact shareholder returns.
- Transaction Background: On March 2, 2026, Select Medical announced an agreement with an investment consortium for acquisition, resulting in shareholders being cashed out and the company's shares ceasing to be publicly traded, thus eliminating their investment options.
- Conflict of Interest Issues: The investigation has revealed significant conflicts of interest in the transaction's structure, potentially rendering the sales process and proposed price unfair to shareholders, especially given that at least one analyst maintained a price target of $19.00 per share.
- Shareholder Action Recommendation: Shareholders of Select Medical are encouraged to contact Kaskela Law for more information regarding their legal rights and options, indicating a potential dissatisfaction with the transaction and a desire for legal recourse.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Select Medical Holdings Corporation (NYSE: SEM) for potential violations of federal securities laws related to its sale to a consortium of executives and directors for $16.50 per share, which may limit shareholder rights.
- FONAR Transaction: FONAR Corporation (NASDAQ: FONR) plans to sell its Class B common stock for $19.00 per share and Class C common stock for $6.34 per share, involving the CEO and certain executives, raising concerns about fiduciary duties to shareholders.
- NorthWestern Energy Deal: NorthWestern Energy Group, Inc. (NASDAQ: NWE) is set to sell to Black Hills Corp. for 0.98 shares of Black Hills per share of NorthWestern, resulting in shareholders owning approximately 44% of the combined entity, which may impact their future interests.
- Shareholder Rights Protection: Halper Sadeh LLC aims to secure increased consideration, additional disclosures, and other relief for shareholders, emphasizing the importance of protecting investor rights and ensuring fair treatment in corporate transactions.
See More
